1. Home
  2. ATYR vs APEI Comparison

ATYR vs APEI Comparison

Compare ATYR & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • APEI
  • Stock Information
  • Founded
  • ATYR 2005
  • APEI 1991
  • Country
  • ATYR United States
  • APEI United States
  • Employees
  • ATYR N/A
  • APEI N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • APEI Other Consumer Services
  • Sector
  • ATYR Health Care
  • APEI Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • APEI Nasdaq
  • Market Cap
  • ATYR 228.1M
  • APEI 253.0M
  • IPO Year
  • ATYR 2015
  • APEI 2007
  • Fundamental
  • Price
  • ATYR $3.03
  • APEI $19.87
  • Analyst Decision
  • ATYR Strong Buy
  • APEI Buy
  • Analyst Count
  • ATYR 4
  • APEI 4
  • Target Price
  • ATYR $19.25
  • APEI $21.00
  • AVG Volume (30 Days)
  • ATYR 927.6K
  • APEI 148.5K
  • Earning Date
  • ATYR 11-07-2024
  • APEI 11-12-2024
  • Dividend Yield
  • ATYR N/A
  • APEI N/A
  • EPS Growth
  • ATYR N/A
  • APEI N/A
  • EPS
  • ATYR N/A
  • APEI 0.56
  • Revenue
  • ATYR $235,000.00
  • APEI $613,253,000.00
  • Revenue This Year
  • ATYR N/A
  • APEI $5.73
  • Revenue Next Year
  • ATYR $2,057.69
  • APEI $2.95
  • P/E Ratio
  • ATYR N/A
  • APEI $35.66
  • Revenue Growth
  • ATYR N/A
  • APEI 2.18
  • 52 Week Low
  • ATYR $1.14
  • APEI $6.67
  • 52 Week High
  • ATYR $3.80
  • APEI $21.04
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 51.78
  • APEI 72.52
  • Support Level
  • ATYR $2.88
  • APEI $18.60
  • Resistance Level
  • ATYR $3.80
  • APEI $19.51
  • Average True Range (ATR)
  • ATYR 0.24
  • APEI 1.02
  • MACD
  • ATYR -0.07
  • APEI 0.22
  • Stochastic Oscillator
  • ATYR 22.22
  • APEI 94.61

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About APEI American Public Education Inc.

American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: